Annovis Bio (ANVS): CEO bought ~$200K

~$200K

Approx. value · 98K sh @ $2.05

1.21M

Holds after · shares reported

Traded

Oct 28, 2025

Filed

Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 25, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective September 25, 2025, Annovis Bio, Inc. (the “Company”) appointed Mark Guerin, age 57, as Chief Financial Officer of the Company. Prior to joining the Company, Mr. Guerin served as Chief Financial Officer of Onconova Therapeutics, now known as Traws Pharma, Inc. (Nasdaq: TRAW) from 2016 through February, 2025.”
2. Oct 10, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
3. Oct 26, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
4. Oct 28, 2025 · this disclosureInsider · First insider buy since Oct 2021CEO purchased ~$200K of ANVS shares in the open market

What came next

1. Oct 28, 2025Insider · Largest insider buy since 2020Director purchased ~$2M of ANVS shares in the open market
2. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 14, 2025InsiderDirector purchased ~$32K of ANVS shares in the open market
4. Nov 21, 2025Insider · 1 personInsiders: 2 purchases (~$70K)
5. Nov 24, 2025Insider · 1 personInsiders: 8 purchases (~$320K)
6. Dec 8, 2025Insider · 1 personInsiders: 2 purchases (~$194K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Annovis Bio

For Annovis Bio, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANVS page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Annovis Bio

• SEC Form 4Nov 6, 2026
• SEC Schedule 13GOct 15, 2026
• SEC Form 4May 22, 2026
• SEC Form 4May 22, 2026
• SEC Form 4May 22, 2026
• SEC Form 4Apr 3, 2026

Everything OQRO holds on this company is on its ANVS page.